Alessa Therapeutics, Inc.
Edit

Alessa Therapeutics, Inc.

http://alessatherapeutics.com/
Last activity: 09.01.2025
Active
Categories: ActiveAlternativeBioTechDeliveryDevelopmentDrugHardwareLocalProduct
Alessa Therapeutics is developing localized treatments for solid organ disease.
Mentions
5
Location: United States, California, San Carlos
Employees: 1-10
Total raised: $15M
Founded date: 2018

Investors 3

Funding Rounds 1

DateSeriesAmountInvestors
19.12.2024Seed$15M-

Mentions in press and media 5

DateTitleDescription
09.01.2025Alessa Therapeutics Announces First Patient Enrolled in Enolen Study for Localized Drug Delivery for Prostate CancerSAN CARLOS, CA, UNITED STATES, January 9, 2025 /EINPresswire.com/ -- Alessa Therapeutics, Inc., a privately held drug development company developing an innovative and proprietary localized drug delivery technology for the treatment of prost...
19.12.2024Alessa Therapeutics: Drug Delivery Technology Company Raises $15 Million (Seed)Alessa Therapeutics – a clinical-stage drug development company pioneering an innovative and proprietary localized drug delivery technology for the early interception of cancer and other diseases – announced the closing of a $15 million see...
13.12.2024Alessa Therapeutics Closes $15M Seed FinancingAlessa Therapeutics, a San Carlos, CA-based clinical-stage drug development company, raised $15M in Seed funding. The round was led by Mission BioCapital, with participation from Johnson & Johnson. The company intends to use the funds t...
12.12.2024Alessa Therapeutics Announces Closing $15M Seed FinancingAlessa is well positioned to advance our pipeline and leverage our platform of tissue-targeted drug delivery for the treatment of prostate cancer and other solid organ diseases.” — Pamela Munster, M.D., Founder & Chief Executive Officer...
-Alessa Therapeutics“We drive innovation in oncology and solid organ disease through development of advanced treatment and early interception.”

Reviews 0

Sign up to leave a review

Sign up Log In